|
Patterns of prostate cancer management across Canadian prostate cancer treatment specialists. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Astellas Pharma; Janssen |
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen |
|
|
|
Honoraria - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen; Sanofi |
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Sanofi |
|
|
Honoraria - Astellas Scientific and Medical Affairs Inc; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer |
Research Funding - Agensys; AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Oncogenex; Roche/Genentech; Sanofi |
|
|
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Roche Pharma AG |
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi |
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi |
|
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Sanofi |
Research Funding - AstraZeneca (Inst); Janssen (Inst) |
|
|
No Relationships to Disclose |
|
|
|
|
|
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi |
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi |
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst) |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi |
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst) |